Your session is about to expire
← Back to Search
Continuous Positive Airway Pressure use for Altitude Hypoxia
Study Summary
This trial explored using CPAP devices to reduce dyspnea and oxygen levels in individuals travelling at high altitudes, with promising results. It was found that CPAP devices are lightweight, portable, and can be powered by batteries; allowing for easier delivery to individuals in need of rescue.
- Altitude Hypoxia
- Low Oxygen Levels
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 4 trial • 74 Patients • NCT01807897Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a condition called congestive heart failure, which affects how your heart pumps blood.You have had a heart attack in the past.You are currently taking medications that prevent blood from clotting.You have a history of long-term breathing problems like asthma, COPD, or ILD.You are experiencing changes in your thinking, memory, or behavior.You are currently taking medication to prevent altitude-related illnesses.You have a condition called obstructive sleep apnea and are currently using a nighttime device called CPAP to help you breathe while you sleep.You have a heart condition called coronary artery disease.You are currently taking medications called calcium channel blockers.You are currently using oxygen from a tank or machine to help you breathe.You have difficulty moving or walking.You have too much hair on your face.You have a history of high altitude pulmonary edema (HAPE).You have a neurological disorder.You have difficulty thinking or remembering things.You have a fear of small spaces.
- Group 1: Continuous Positive Airway Pressure use
- Group 2: Ambient air
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who meets the criteria to be enrolled in this clinical trial?
"Patients who have low levels of oxygen and are between 18-70 years old may be qualified to join this research study. Up to 25 individuals will gain entry into the experiment."
Does the protocol for this research endeavor stipulate an age cap?
"This research study requires that participants are between 18 and 70 years old in order to be considered for enrollment."
Is access to this research project currently available for participants?
"As stated on clinicaltrials.gov, this medical trial is no longer recruiting patients; it was first published on July 22nd 2019 and its last update occurred a few days later on the 24th of that same month. Fortunately, there are 133 active trials seeking enrolment at present moment."
Share this study with friends
Copy Link
Messenger